Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gema Mateo

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Haematologica|September 13, 2003
Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myelomaGema Mateo, Mercedes Corral, Julia Almeida, et al.
Haematologica|November 3, 2009
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patientsBruno Paiva, Maria-Belén Vidriales, Jose J Pérez, et al.
Blood|July 9, 2004
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myelomaNorma C Gutiérrez, Juan L García, Jesús M Hernández, et al.
Blood|February 5, 2005
Multifunctional role of Erk5 in multiple myelomaXonia Carvajal-Vergara, Soraya Tabera, Juan C Montero, et al.
Blood|February 28, 2002
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcomeJesús F San Miguel, Julia Almeida, Gema Mateo, et al.
Haematologica|October 13, 2005
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometryMaría Eugenia Sarasquete, Ramón García-Sanz, David González, et al.
International Journal of Cancer|November 13, 2008
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the diseaseMartin Perez-Andres, Julia Almeida, Marta Martin-Ayuso, et al.
Blood|June 20, 2007
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cellsErnesto Pérez-Persona, María-Belén Vidriales, Gema Mateo, et al.
British Journal of Haematology|October 14, 2009
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cellsErnesto Pérez-Persona, Gema Mateo, Ramón García-Sanz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Genetic abnormalities and patterns of antigenic expression in multiple myelomaGema Mateo, Mariana Castellanos, Ana Rasillo, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Haematologica|September 13, 2003
Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myelomaGema Mateo, Mercedes Corral, Julia Almeida, et al.
Haematologica|November 3, 2009
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patientsBruno Paiva, Maria-Belén Vidriales, Jose J Pérez, et al.
Blood|July 9, 2004
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myelomaNorma C Gutiérrez, Juan L García, Jesús M Hernández, et al.
Blood|February 5, 2005
Multifunctional role of Erk5 in multiple myelomaXonia Carvajal-Vergara, Soraya Tabera, Juan C Montero, et al.
Blood|February 28, 2002
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcomeJesús F San Miguel, Julia Almeida, Gema Mateo, et al.
Haematologica|October 13, 2005
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometryMaría Eugenia Sarasquete, Ramón García-Sanz, David González, et al.
International Journal of Cancer|November 13, 2008
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the diseaseMartin Perez-Andres, Julia Almeida, Marta Martin-Ayuso, et al.
Blood|June 20, 2007
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cellsErnesto Pérez-Persona, María-Belén Vidriales, Gema Mateo, et al.
British Journal of Haematology|October 14, 2009
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cellsErnesto Pérez-Persona, Gema Mateo, Ramón García-Sanz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Genetic abnormalities and patterns of antigenic expression in multiple myelomaGema Mateo, Mariana Castellanos, Ana Rasillo, et al.
Pageof 3